SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-001152
Filing Date
2019-01-25
Accepted
2019-01-25 16:05:18
Documents
1
Period of Report
2019-01-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20190125.htm 8-K 31407
  Complete submission text file 0001564590-19-001152.txt   32729
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 19542598
SIC: 2834 Pharmaceutical Preparations